What Is Stroke (medical Condition)?

Stroke is a cerebrovascular medical condition characterized by the sudden interruption of blood flow to part of the brain, resulting in the rapid onset of focal neurological deficits that may persist beyond 24 hours or lead to death. The underlying mechanism is either the occlusion of a cerebral blood vessel, producing ischemia, or the rupture of a vessel, producing hemorrhage into or around brain tissue. Stroke is the second leading cause of death worldwide and one of the primary causes of long-term adult disability, making it a major focus of biomedical engineering, neuroradiology, and clinical neuroscience.

The organ-level consequence of stroke is quantifiable and time-dependent: an affected brain loses approximately 1.9 million neurons per minute during the ischemic phase, which frames all clinical and engineering responses around speed of detection and intervention.

Types of Stroke

Strokes are divided into two principal categories based on their mechanism. Ischemic stroke, which accounts for roughly 85 percent of all strokes globally, results from thrombotic or embolic occlusion that blocks perfusion to a defined vascular territory. The thrombotic form arises from atherosclerotic plaque rupture in cerebral or carotid arteries; the embolic form most often originates in the heart, particularly in patients with atrial fibrillation, valvular disease, or recent myocardial infarction. The NCBI StatPearls chapter on ischemic stroke provides a systematic account of its pathophysiology and classification by territory. Hemorrhagic stroke accounts for the remaining 10 to 15 percent of strokes but carries significantly higher mortality. It is subdivided into intracerebral hemorrhage, in which blood extravasates directly into brain parenchyma, and subarachnoid hemorrhage, in which bleeding occurs in the space between the brain and its surrounding membranes, as described in the NCBI StatPearls hemorrhagic stroke reference.

Diagnosis and Clinical Assessment

Rapid identification of stroke relies on standardized screening tools and imaging. The FAST mnemonic, which prompts assessment of Facial droop, Arm weakness, Speech difficulty, and Time of onset, is used in pre-hospital and emergency settings to flag patients for urgent neurological workup. Formal severity scoring uses the National Institutes of Health Stroke Scale, a 15-item neurological examination that quantifies deficits in level of consciousness, gaze, vision, facial palsy, motor function, ataxia, and language. Non-contrast computed tomography is the standard first-line imaging study to exclude hemorrhage before thrombolytic therapy is considered. Magnetic resonance imaging with diffusion-weighted sequences identifies ischemic tissue within minutes of onset and can delineate the penumbra of salvageable neurons that constitutes the therapeutic target.

Treatment and Intervention

Time-critical therapies define stroke management. For ischemic stroke, intravenous recombinant tissue plasminogen activator (tPA), administered at 0.9 mg/kg to a maximum of 90 mg over 60 minutes, dissolves the clot mechanically blocking the vessel and is effective when given within 4.5 hours of symptom onset. Mechanical thrombectomy, in which an endovascular catheter retrieves the obstructing clot under fluoroscopic guidance, extends the treatment window to 24 hours in patients with large vessel occlusions confirmed by perfusion imaging, as established by the DAWN and DEFUSE 3 trials. As documented in PMC research on acute ischemic stroke management, eligible patients treated with thrombectomy within the first six hours achieve favorable outcomes at substantially higher rates than those treated with intravenous therapy alone. For hemorrhagic stroke, management focuses on controlling blood pressure, reversing anticoagulation, and in selected cases surgical evacuation of the hematoma.

Applications

Stroke research and management have applications in a wide range of disciplines, including:

• Biomedical engineering, where wearable sensors and portable ultrasound devices enable pre-hospital stroke detection
• Neurorehabilitation robotics, assisting motor recovery in post-stroke patients with arm and gait impairment
• Medical imaging and machine learning, with algorithms trained to detect ischemic penumbra and large vessel occlusions on CT perfusion scans
• Telemedicine, where remote neurologist consultation expands thrombolytic treatment access in rural hospitals
• Epidemiology and public health, tracking stroke incidence, modifiable risk factors, and population-level outcomes